SynthesisFrontiers in oncology2026
Single-port compared with conventional laparoscopic ovarian cystectomy for benign ovarian cysts: a systematic review and meta-analysis.
Synthesis in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate current evidence on the safety and impact on ovarian reserve of single-port laparoscopic cystectomy (SLC) for the treatment of benign ovarian cysts. Methods: We comprehensively searched PubMed, Embase, the Cochrane Library, and ClinicalTrials.gov from their inception to 31 December 2025. We included randomized controlled trials (RCTs) or non-randomized studies (NRSs) comparing SLC with conventional laparoscopic cystectomy (CLC) for benign ovarian cysts. The primary outcomes were postoperative changes in serum anti-Müllerian hormone (AMH) concentration, intraoperative complications, postoperative complications, and cosmetic outcomes. All analyses were performed using random-effects or fixed-effects models. Results: In total, 14 full-text studies involving 1, 691 participants were included in the final analysis. There were no significant differences between SLC and CLC in the incidence of intraoperative complications ( Conclusion: This systematic review and meta-analysis provides evidence that SLC may be offered as a minimally invasive surgical alternative for women with benign ovarian cysts, at the cost of a longer operative time compared with CLC. Given the retrospective design of the majority of the included studies, further large-scale randomized controlled trials are warranted to validate these findings. Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/view/, identifier CRD42024602477.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.